Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

99mTc-HYNIC-TOC scintigraphy is superior to 131I-MIBG imaging in the evaluation of extraadrenal pheochromocytoma.

Chen L, Li F, Zhuang H, Jing H, Du Y, Zeng Z.

J Nucl Med. 2009 Mar;50(3):397-400. doi: 10.2967/jnumed.108.058693. Epub 2009 Feb 17.

2.

99mTc-HYNIC octreotide in neuroblastoma.

Gambini JP, López Lerena JJ, Quagliata A, Hermida JC, Heuguerot C, Alonso O.

Ann Nucl Med. 2008 Nov;22(9):817-9. doi: 10.1007/s12149-008-0201-9. Epub 2008 Nov 28.

PMID:
19039561
3.

Successful chemotherapy and 90Y-DOTATOC in a patient with mediastinal highly aggressive neuroendocrine carcinoma.

Fazio N, Grana C, Pelosi G, Torrisi R, Di Meglio G, Tradati N, Lorizzo K, De Braud F.

Acta Oncol. 2006;45(5):627-9. No abstract available.

PMID:
16864182
4.

GRP receptor-targeted PET of a rat pancreas carcinoma xenograft in nude mice with a 68Ga-labeled bombesin(6-14) analog.

Schuhmacher J, Zhang H, Doll J, Mäcke HR, Matys R, Hauser H, Henze M, Haberkorn U, Eisenhut M.

J Nucl Med. 2005 Apr;46(4):691-9.

5.

99mTc-EDDA/HYNIC-TOC in the management of medullary thyroid carcinoma.

Parisella M, D'Alessandria C, van de Bossche B, Chianelli M, Ronga G, Papini E, Mikolajczak R, Letizia C, De Toma G, Veneziani A, Scopinaro F, Signore A.

Cancer Biother Radiopharm. 2004 Apr;19(2):211-7.

PMID:
15186602

Supplemental Content

Loading ...
Support Center